Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multimodal Proteomics Reveals Dysregulated Secretion and ECM Remodelling in Schizophrenia Patient iPSC-Derived Astrocytes.

Cells·2026
Same author

C26:0-lysophosphatidylcholine in X-linked adrenoleukodystrophy.

Pharmacology & therapeutics·2026
Same author

Generation of a human induced pluripotent stem cell line (iPSC) from a patient with Clark-Baraitser Syndrome.

Stem cell research·2026
Same author

Aminoacyl-tRNA Synthetases: Variant Classification, Functional Assays, and Emerging Therapeutic Strategies.

Journal of inherited metabolic disease·2026
Same author

Prognostic Value of Neurofilament Light Chain and Glial Fibrillary Acidic Protein in ALD-Related Myelopathy.

Annals of clinical and translational neurology·2026
Same author

Generation of two human induced pluripotent stem cell lines (iPSC) from patients with Hao-Fountain Syndrome.

Stem cell research·2026

Related Experiment Video

Updated: Nov 23, 2025

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
07:45

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

Published on: October 21, 2014

8.2K

Evolution of adrenoleukodystrophy model systems.

Roberto Montoro1, Vivi M Heine2,3, Stephan Kemp1,4

  • 1Department of Pediatric Neurology, Emma Children's Hospital, Amsterdam UMC, Amsterdam Leukodystrophy Center, Amsterdam Neuroscience, University of Amsterdam, Amsterdam, The Netherlands.

Journal of Inherited Metabolic Disease
|December 29, 2020
PubMed
Summary
This summary is machine-generated.

X-linked adrenoleukodystrophy (ALD) is a complex neurometabolic disorder caused by ABCD1 gene mutations. This review explores current ALD models and highlights how iPSC technology can advance understanding of this challenging disease.

Keywords:
fatty acidsinborn error of metabolismmodel systemspathogenesisperoxisomes

More Related Videos

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.1K
Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
08:47

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues

Published on: May 8, 2016

24.4K

Related Experiment Videos

Last Updated: Nov 23, 2025

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
07:45

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

Published on: October 21, 2014

8.2K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.1K
Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
08:47

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues

Published on: May 8, 2016

24.4K

Area of Science:

  • Neurology
  • Genetics
  • Metabolic Disorders

Background:

  • X-linked adrenoleukodystrophy (ALD) is a severe neurometabolic disorder affecting multiple organs due to ABCD1 gene mutations.
  • It impairs very long-chain fatty acid degradation, leading to accumulation and neurodegeneration.
  • ALD presents complex phenotypes with high risks of myelopathy and cerebral lesions in males, and myelopathy in adult females.

Purpose of the Study:

  • To review existing ALD modeling strategies.
  • To discuss the limitations of current models in fully recapitulating ALD's neurodegenerative aspects.
  • To introduce induced pluripotent stem cell (iPSC)-derived technologies as a promising approach for better understanding ALD.

Main Methods:

  • Review of various ALD model systems, including single-celled to multicellular organisms and in vitro/in vivo approaches.
  • Analysis of the strengths and weaknesses of each model in replicating ALD pathophysiology.
  • Exploration of emerging iPSC-based modeling techniques.

Main Results:

  • Current ALD models partially recapitulate disease aspects but fail to fully capture the complex neurodegenerative etiology.
  • The diversity of models underscores the inherent complexity of ALD.
  • iPSC-derived technologies offer potential for more comprehensive disease modeling.

Conclusions:

  • Developing a comprehensive ALD model remains challenging due to the disorder's complexity.
  • Existing models provide valuable insights but have limitations.
  • iPSC technology represents a significant advancement for studying ALD pathogenesis and developing therapeutic strategies.